Patrick Gallagher
Patrick Gallagher has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alex H. Cho
Duke University School of Medicine, Duke University Health System, Durham, USA
1 shared publication - Bryce B. Reeve
Department of Population Health Sciences, Duke University, Durham, North Carolina, USA
1 shared publication - Christopher L. Bryson
VA Puget Sound Health Care System, Northwest Center for Outcomes Research in Older Adults, 1660 South Columbian Way, Seattle, WA, 98108, USA.
1 shared publication - Corrine I. Voils
University of Utah, Salt Lake City, USA
1 shared publication - Geoffrey S. Ginsburg
All of Us Research Program, National Institutes of Health
1 shared publication - Gloria M Trujillo
Department of Community and Family Medicine, Duke University School of Medicine, 2100 Erwin Rd, Marshall Pickens Building, DUMC Box 3886, Durham, NC, USA, 27710
1 shared publication
Latest Publications
- 1 December 2012
- Published by Wolters Kluwer Health in Medical Care
- Vol. 50 (12) , 1013-1019
Initial Validation of a Self-Report Measure of the Extent of and Reasons for Medication Nonadherence
Background Self-report measures of medication nonadherence confound the extent of and reasons for medication nonadherence. Each construct is assessed with a different type of psychometric model, which dictates how to establish reliability and validity. Objectives: To evaluate the psychometric properties of a self-report measure of medication nonadherence that assesses separately the extent of nonadherence and reasons for nonadherence. Research Design: Cross-sectional survey involving the new measure and comparison measures to establish convergent, discriminant, and predictive validity. The new measure was readministered 2–21 days later. Subjects: A total of 202 veterans with treated hypertension were recruited from the Durham Veterans Affairs Medical Center. Measures: A new self-report measure assessed the extent of nonadherence and reasons for nonadherence. Comparison measures included self-reported medication self-efficacy, beliefs about medications, impression management, conscientiousness, habit strength, and an existing nonadherence measure. Results: Three items assessing the extent of nonadherence produced reliable scores for this sample, α=0.84 (95% confidence interval, 0.80–0.87). Correlations with comparison measures provided evidence of convergent and discriminant validity. Correlations with systolic (r=0.27, Pr=0.27, PReasons for nonadherence were assessed with 21 independent items. Intraclass correlations were 0.58 for the extent score and ranged from 0.07 to 0.64 for the reasons. Conclusions: The dual conceptualization of medication nonadherence allowed a stronger evaluation of the reliability and validity than was previously possible with measures that confounded these 2 constructs. Measurement of self-reported nonadherence consistent with psychometric principles will enable reliable, valid evaluation of interventions to reduce nonadherence.
- 1 December 2012
- Published by Wolters Kluwer Health in Medical Care
- Vol. 50 (12) , 1013-1019
Initial Validation of a Self-Report Measure of the Extent of and Reasons for Medication Nonadherence
Background Self-report measures of medication nonadherence confound the extent of and reasons for medication nonadherence. Each construct is assessed with a different type of psychometric model, which dictates how to establish reliability and validity. Objectives: To evaluate the psychometric properties of a self-report measure of medication nonadherence that assesses separately the extent of nonadherence and reasons for nonadherence. Research Design: Cross-sectional survey involving the new measure and comparison measures to establish convergent, discriminant, and predictive validity. The new measure was readministered 2–21 days later. Subjects: A total of 202 veterans with treated hypertension were recruited from the Durham Veterans Affairs Medical Center. Measures: A new self-report measure assessed the extent of nonadherence and reasons for nonadherence. Comparison measures included self-reported medication self-efficacy, beliefs about medications, impression management, conscientiousness, habit strength, and an existing nonadherence measure. Results: Three items assessing the extent of nonadherence produced reliable scores for this sample, α=0.84 (95% confidence interval, 0.80–0.87). Correlations with comparison measures provided evidence of convergent and discriminant validity. Correlations with systolic (r=0.27, Pr=0.27, PReasons for nonadherence were assessed with 21 independent items. Intraclass correlations were 0.58 for the extent score and ranged from 0.07 to 0.64 for the reasons. Conclusions: The dual conceptualization of medication nonadherence allowed a stronger evaluation of the reliability and validity than was previously possible with measures that confounded these 2 constructs. Measurement of self-reported nonadherence consistent with psychometric principles will enable reliable, valid evaluation of interventions to reduce nonadherence.
- Open Access
- 18 January 2012
- Published by Springer Nature in BMC Health Services Research
- Vol. 12 (1) , 16
Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design
Type 2 diabetes is a prevalent chronic condition globally that results in extensive morbidity, decreased quality of life, and increased health services utilization. Lifestyle changes can prevent the development of diabetes, but require patient engagement. Genetic risk testing might represent a new tool to increase patients' motivation for lifestyle changes. Here we describe the rationale, development, and design of a randomized controlled trial (RCT) assessing the clinical and personal utility of incorporating type 2 diabetes genetic risk testing into comprehensive diabetes risk assessments performed in a primary care setting.
- 18 January 2012
- Published by Springer Nature in BMC Health Services Research
- Vol. 12 (1) , 16
Open AccessEffect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design
Type 2 diabetes is a prevalent chronic condition globally that results in extensive morbidity, decreased quality of life, and increased health services utilization. Lifestyle changes can prevent the development of diabetes, but require patient engagement. Genetic risk testing might represent a new tool to increase patients' motivation for lifestyle changes. Here we describe the rationale, development, and design of a randomized controlled trial (RCT) assessing the clinical and personal utility of incorporating type 2 diabetes genetic risk testing into comprehensive diabetes risk assessments performed in a primary care setting.